Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts, Notification of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug Substance), Andover, Massachusetts, 70439 [2021-26761]
Download as PDF
Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Notices
New York Advisory Committee. Persons
interested in the work of this Committee
are also directed to the Commission’s
website, www.usccr.gov; persons may
also contact the Regional Programs Unit
office at the above email or phone
number.
DEPARTMENT OF COMMERCE
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
International Trade Administration
[B–80–2021]
[C–570–140]
Foreign-Trade Zone (FTZ) 27—Boston,
Massachusetts, Notification of
Proposed Production Activity, Wyeth
Pharmaceuticals, LLC (mRNA Bulk
Drug Substance), Andover,
Massachusetts
Certain Mobile Access Equipment and
Subassemblies Thereof From the
People’s Republic of China:
Countervailing Duty Order and
Amended Final Affirmative
Countervailing Duty Determination
AGENCY:
On September 2, 2021, the Executive
Secretary of the Foreign-Trade Zones
(FTZ) Board docketed an application
submitted by the Port Authority of New
York and New Jersey, grantee of FTZ 49,
requesting subzone status subject to the
existing activation limit of FTZ 49, on
behalf of Getinge Group Logistics
Americas LLC, in Dayton, New Jersey.
The application was processed in
accordance with the FTZ Act and
Regulations, including notice in the
Federal Register inviting public
comment (86 FR 50524–50525,
September 9, 2021). The FTZ staff
examiner reviewed the application and
determined that it meets the criteria for
approval. Pursuant to the authority
delegated to the FTZ Board Executive
Secretary (15 CFR 400.36(f)), the
application to establish Subzone 49W
was approved on December 7, 2021,
subject to the FTZ Act and the Board’s
regulations, including Section 400.13,
and further subject to FTZ 49’s 2,000acre activation limit.
Wyeth Pharmaceuticals, LLC (Wyeth)
submitted a notification of proposed
production activity to the FTZ Board for
its facility in Andover, Massachusetts
within Subzone 27R. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on December 3, 2021.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status materials/
components described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed materials/components
would be added to the production
authority that the Board previously
approved for the operation, as reflected
on the Board’s website.
The proposed foreign-status materials
and components include
Pyrophosphatase Inorganic Animal
Origin Free (AOF), Rnase-Free Dnase I,
Rnase Inhibitor, and Uridine-5′triphosphate (UTP) (duty rate ranges
from duty-free to 6.5%). The request
indicates that certain materials/
components are subject to duties under
Section 301 of the Trade Act of 1974
(section 301), depending on the country
of origin. The applicable Section 301
decisions require subject merchandise
to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
January 19, 2022.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at Diane.Finver@trade.gov.
Dated: December 7, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
Dated: December 6, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021–26760 Filed 12–9–21; 8:45 am]
[FR Doc. 2021–26761 Filed 12–9–21; 8:45 am]
BILLING CODE 3510–DS–P
BILLING CODE 3510–DS–P
Agenda
I. Welcome and Roll Call
II. Announcements and Updates
III. Approval of Minutes
IV. Discussion: Committee’s Draft
Report on Eviction Policy and
Enforcement in New York
V. Potential Vote To Approve the Draft
Report
VI. Public Comment
VII. Review Next Steps
VIII. Adjournment
Dated: December 6, 2021.
David Mussatt,
Supervisory Chief, Regional Programs Unit.
[FR Doc. 2021–26705 Filed 12–9–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[S–133–2021]
Approval of Subzone Status, Getinge
Group Logistics Americas LLC,
Dayton, New Jersey
jspears on DSK121TN23PROD with NOTICES1
70439
VerDate Sep<11>2014
17:03 Dec 09, 2021
Jkt 256001
PO 00000
Frm 00010
Fmt 4703
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: Based on affirmative final
determinations by the Department of
Commerce (Commerce) and
International Trade Commission (ITC),
Commerce is issuing a countervailing
duty (CVD) order on certain mobile
access equipment and subassemblies
thereof (mobile access equipment) from
the People’s Republic of China (China).
In addition, Commerce is amending its
final determination with respect to
mobile access equipment from China to
correct several ministerial errors.
DATES: Applicable December 10, 2021.
FOR FURTHER INFORMATION CONTACT:
Theodore Pearson or Michael Romani,
AD/CVD Operations, Office I,
Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230; telephone: (202) 482–2631 or
(202) 482–0198, respectively.
SUPPLEMENTARY INFORMATION:
Background
In accordance with section 705(a),
705(d), and 777(i) of the Tariff Act of
1930, as amended (the Act), on October
19, 2021, Commerce published its
affirmative final determination that
countervailable subsides are being
provided to producers and exporters of
mobile access equipment from China.1
The Coalition of American
Manufacturers of Mobile Access
Equipment (the petitioner) and Lingong
Jinan Heavy Machinery Co., Ltd.
(LGMG) submitted timely allegations on
the record that Commerce made several
ministerial errors in the Final
Determination.2 Section 705(e) of the
1 See Certain Mobile Access Equipment and
Subassemblies Thereof from the People’s Republic
of China: Final Affirmative Countervailing Duty
Determination, 86 FR 57809 (October 19, 2021)
(Final Determination).
2 See Petitioner’s Letter, ‘‘Certain Mobile Access
Equipment and Subassemblies Thereof from the
People’s Republic of China: Ministerial Error
Allegations,’’ dated October 20, 2021 (Petitioner
Ministerial Error Allegations); see also LGMG’s
Letter, ‘‘Certain Mobile Access Equipment and
Continued
Sfmt 4703
E:\FR\FM\10DEN1.SGM
10DEN1
Agencies
[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
[Notices]
[Page 70439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26761]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-80-2021]
Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Notification
of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk
Drug Substance), Andover, Massachusetts
Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of
proposed production activity to the FTZ Board for its facility in
Andover, Massachusetts within Subzone 27R. The notification conforming
to the requirements of the Board's regulations (15 CFR 400.22) was
received on December 3, 2021.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components described
in the submitted notification (summarized below) and subsequently
authorized by the Board. The benefits that may stem from conducting
production activity under FTZ procedures are explained in the
background section of the Board's website--accessible via
www.trade.gov/ftz. The proposed materials/components would be added to
the production authority that the Board previously approved for the
operation, as reflected on the Board's website.
The proposed foreign-status materials and components include
Pyrophosphatase Inorganic Animal Origin Free (AOF), Rnase-Free Dnase I,
Rnase Inhibitor, and Uridine-5'-triphosphate (UTP) (duty rate ranges
from duty-free to 6.5%). The request indicates that certain materials/
components are subject to duties under Section 301 of the Trade Act of
1974 (section 301), depending on the country of origin. The applicable
Section 301 decisions require subject merchandise to be admitted to
FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is January 19,
2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
[email protected].
Dated: December 6, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-26761 Filed 12-9-21; 8:45 am]
BILLING CODE 3510-DS-P